CoverageForm 410-K10-Q8-K13D13G13F

N/A Lord Abbett Private Credit Fund S - 8-K

Filed Apr 23, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0000930413-26-001191
3.027.018.01

Item 3.02 - Unregistered Sales of Equity Securities

158 words

Item 3.02. Unregistered Sales of Equity
Securities.

As of April 1, 2026, Lord Abbett Private
Credit Fund S (“we”, the “Company” or the “Fund”), issued and sold approximately 377,517 of the Company’s
common shares of beneficial interest (the “Common Shares”) for an aggregate offering price of approximately $9.3 million,
reflecting a purchase price of $24.73 per Common Share (with the final number of Common Shares being determined on April 17,
2026).

The offer and sale of Common Shares was
made pursuant to subscription agreements entered into by the Company and its shareholders. The issuance of the Common Shares is
exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), provided
by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Company relied, in part, upon representations
from the shareholders in the subscription agreements that each shareholder was an accredited investor as defined in Regulation
D under the Securities Act.

Item 7.01 - Regulation FD Disclosure

607 words

Item 7.01. Regulation FD Disclosure.

Company’s Portfolio:

As of March 31, 2026, the Company had made
loans to 47 portfolio companies, held an equity position in one portfolio company, and held one investment in a joint venture,
with an aggregate loan commitment amount of approximately $436 million and par value of approximately $336 million. The portfolio
consists of 94% senior secured debt investments and 6% investment in a joint venture, based on par value or in the case of investments
in a joint venture, cost. As of March 31, 2026, 100% of the debt investments, based on par value, in the Company’s portfolio were
at floating rates. As of March 31, 2026, 99% of the Company’s total loan commitments were in private senior secured loans.
The following table presents information concerning portfolio companies to which the Company has made loans.

Portfolio
Company Metrics (1) :

Median 12-month EBITDA:

$81
million (2)

Weighted average net leverage:

4.7x (2)(3)

Weighted average loan to
value:

42% (2)(4)

Weighted average interest
coverage:

2.4x (2)(5)

Weighted average yield on
debt investments, at cost:

9.2% (6)

(1)

Amounts
were derived from the most recently available financial statements provided by portfolio
companies which have not been independently verified by us and may reflect a normalized
or adjusted amount. Such amounts have not been independently estimated by us, and accordingly,
we take no responsibility for such numbers and make no representation or warranty in
respect of this information.

(2)

Metrics
exclude one liquid loan. Metrics also exclude one recurring revenue investment, which
are investments in portfolio companies in which the Company lends based on a multiple
of recurring revenue generated by the portfolio company and not based on a multiple of
EBITDA. Weighted average metrics are calculated as a percentage of funded par value of
debt investments.

(3)

Net
leverage is the ratio of total senior debt minus cash divided by EBITDA and taking into
account leverage through the tranche to which the Company is a lender.

(4)

Calculated
using total senior debt minus cash divided by total enterprise value estimated by the
private equity sponsor or market comparables and taking into account leverage through
the tranche to which the Company is a lender.

(5)

Interest
coverage for a particular portfolio company is calculated by taking EBITDA and dividing
by annualized latest reported interest expense.

(6)

Computed
as (a) the annual stated spread, plus reference rate, as applicable, plus the annual
accretion of discounts, plus the annual unused fees, as applicable on debt securities
divided by (b) total debt investments at cost included in such securities. Actual yields
earned over the life of each investment could differ materially from the yields presented
herein.

The table below shows the Company’s loan
investment activity during the period March 1, 2026, through March 31, 2026. Amounts shown for commitment amount and par value
are as of March 31, 2026:

Issuer

Commitment

Amount

($ in millions)

Par Amount

($ in millions)

AA&D Midco Inc

$25.0

$23.7

AMP Purchaser LLC

$9.3

$8.2

Databricks Inc

$2.5

$0.5

LR Purchaser LLC

$13.3

$10.9

NDT Global Holding Inc.

$10.9

$0.0

Total

$61.0

$43.3

The table below describes investments by
industry composition based on par value or, in the case of equity investments, cost as of March 31, 2026:

Industry

Par or Cost

($ in millions)

% of Total

Health Care Providers & Services

$48.0

14.3%

Commercial Services & Supplies

43.8

13.0

Air Freight & Logistics

39.9

11.9

Aerospace & Defense

34.9

10.4

Software

30.8

9.2

Machinery

19.3

5.7

Electrical Equipment

16.9

5.0

IT Services

15.1

4.5

Health Care Equipment & Supplies

14.6

4.3

Food Products

12.9

3.8

Others

59.8

17.9

Total

$336.0

100.0%

Item 8.01 - Other Events

141 words

Item 8.01. Other Events.

Distribution:

On April 20, 2026,
the Company declared a distribution of approximately $0.19 per share to shareholders of record as of April 30, 2026 to be paid
on or about May 29, 2026.

Net
Asset Value

As of March 31, 2026, the Company’s
aggregate net asset value (“NAV”) was approximately $185 million. The NAV per share of Common Shares as of March 31,
2026, as determined in accordance with the Company’s valuation policy, was $24.73 per Common Share.

Final results related to all of the above
information and other information may differ materially as a result of the completion of the Company’s financial closing
procedures, which will occur between the date hereof and the completion of the financial statements and the filing of the Company’s
quarterly report on Form 10-Q for the quarter ending March 31, 2026.